Clario accelerates your clinical trial from initiation to implementation. LEARN MORE →
The theme of the 19th DIA Japan Annual Meeting is “New “Quest for the future”- Moving Creativity and Innovation Forward in “New Normal” – ”. This means that we who have experienced COVID 19 will explore the future in a new normal environment. COVID19 has brought us lives and environments that we have never experienced before. While face-to-face work declined dramatically, digital transformation accelerated at once. They also promoted extremely rapid development of vaccines and therapeutic agents, as well as new clinical trial models including telemedicine. In addition, the importance of self-care associated with refraining from visiting medical institutions and the importance of addressing the issue of infodemics were reaffirmed.
In the new normal environment that has brought about by COVID19, we are seeking to implement new clinical trials, implement safety measures, disseminate information, develop new modalities, and respond to self-care. There is a need for new Creativity and Innovation on pharmaceuticals, medical devices, regenerative medicine, and other products for the future. We wish to share and discuss how to proceed with this in advance, as well as the efforts, experiences and ideas of you, and to make it a conference to proceed further in advance. It is hoped that discussions will take place from a variety of positions and perspectives.